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J Appl Physiol 104: 1341–1350, 2008. First published March 20,
2008; doi:10.1152/japplphysiol.01364.2007.—Patients with chronic
obstructive pulmonary disease (COPD) have slowed pulmonary O2
uptake (V˙ O2p) kinetics during exercise, which may stem from inade-
quate muscle O2 delivery. However, it is currently unknown how
COPD impacts the dynamic relationship between systemic and mi-
crovascular O2 delivery to uptake during exercise. We tested the
hypothesis that, along with slowed V˙ O2p kinetics, COPD patients have
faster dynamics of muscle deoxygenation, but slower kinetics of
cardiac output (Q˙ T) following the onset of heavy-intensity exercise.
We measured V˙ O2p, Q˙ T (impedance cardiography), and muscle deox-
ygenation (near-infrared spectroscopy) during heavy-intensity exer-
cise performed to the limit of tolerance by 10 patients with moderate-
to-severe COPD and 11 age-matched sedentary controls. Variables
were analyzed by standard nonlinear regression equations. Time to
exercise intolerance was significantly (P  0.05) lower in patients and
related to the kinetics of V˙ O2p (r 0.70; P  0.05). Compared with
controls, COPD patients displayed slower kinetics of V˙ O2p (42  13
vs. 73  24 s) and Q˙ T (67  11 vs. 96  32 s), and faster overall
kinetics of muscle deoxy-Hb (19.9  2.4 vs. 16.5  3.4 s). Conse-
quently, the time constant ratio of O2 uptake to mean response time of
deoxy-Hb concentration was significantly greater in patients, suggest-
ing a slower kinetics of microvascular O2 delivery. In conclusion, our
data show that patients with moderate-to-severe COPD have impaired
central and peripheral cardiovascular adjustments following the onset
of heavy-intensity exercise. These cardiocirculatory disturbances neg-
atively impact the dynamic matching of O2 delivery and utilization
and may contribute to the slower V˙ O2p kinetics compared with
age-matched controls.
blood flow; chronic obstructive pulmonary disease; hemodynamics;
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FOLLOWING THE ONSET OF EXERCISE, the dynamic increase in
pulmonary oxygen uptake (V˙ O2p) is slowed in patients with
chronic obstructive pulmonary disease (COPD) compared with
age-matched controls (12, 34, 36, 40, 41, 45). The slowed
kinetics of V˙ O2p leads to greater reliance on oxygen-indepen-
dent metabolic pathways and accumulation of by-products that
might be related to increased muscle fatigability (e.g., phos-
phate and H) (38). Thus the slow increase in V˙ O2p may be
mechanistically associated with the marked decrement in ex-
ercise tolerance that characterizes this patient population (1, 3,
30, 33, 42, 44).
Derangements in the diffusive and convective transport of
O2 to skeletal muscle mitochondria (44, 45) and intramyocyte
metabolic machinery (3, 54) could explain the slowness of V˙ O2
kinetics in COPD. During moderate-intensity (sub-“lactate
threshold”) exercise, the existing literature suggests that V˙ O2
kinetics are limited by intramyocyte perturbations associated
with COPD (34, 40, 45). However, a different scenario may
emerge during heavy (supra-“lactate threshold”) exercise. In
this situation, higher ventilation and disturbances in mechanics
of breathing (1, 2, 49, 50), hypoxemia (36, 45), pulmonary
hemodynamics (14), autonomic balance (26), and peripheral
vasodilation (see DISCUSSION for details) could slow the re-
sponse of systemic (central) and peripheral (microvascular) O2
delivery to a point where the kinetics of V˙ O2 might become
limited by O2 availability (38).
In this context, it can be anticipated that, if COPD slows the
dynamic increase in muscle microvascular O2 delivery (Q˙ O2 mv) to a
greater extent than the rate of O2 utilization, as indicated by the
V˙ O2 response following the onset of exercise, muscle micro-
vascular O2 extraction would be accelerated (9, 16, 18). In this
circumstance, the microvascular pressure of O2 might tran-
siently reach levels sufficiently low to impair O2 transfer from
capillary to mitochondria (38), predisposing the kinetics of V˙ O2
to O2 delivery (convective and/or diffusive) limitation (39). In
contrast, if the rate of increase in muscle microvascular O2
extraction is slowed in COPD patients at the onset of exercise,
it would suggest that muscle O2 delivery is in excess of
utilization throughout this transitional phase. These responses
have been interpreted as V˙ O2 kinetics being limited by activa-
tion of intracellular metabolic pathways (5, 10). This issue has
been explored in healthy aging (9, 15, 16) and some chronic
diseases [e.g., diabetes (6), peripheral arterial disease (5), and
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heart failure (10)]. However, the effects of COPD on the
dynamics of (estimated) muscle microvascular O2 extraction
and central cardiovascular responses following the onset of
heavy exercise remain unclear.
The main hypothesis tested in the present study is that the
sluggish kinetics of V˙ O2p commonly found in COPD patients
are accompanied by faster adjustment of skeletal muscle de-
oxygenation (or estimated O2 extraction) and slower “central”
cardiovascular dynamics [cardiac output (Q˙ T)] following the
onset of heavy-intensity exercise. Our secondary aims were to
determine whether 1) an indicator of the dynamics of Q˙ O2 mv is
associated with the kinetics of Q˙ T (approximately systemic O2
delivery); and 2) the ability of COPD patients to sustain
exercise of heavy intensity is related to the kinetics of V˙ O2p
during the same exercise bout.
METHODS
Subjects
The study population comprised 10 men with clinical and func-
tional diagnosis of COPD, according to the Global Initiative for
Obstructive Lung Disease (GOLD) criteria (33), and 11 age- and
sex-matched sedentary controls. The patients were a subgroup of
individuals referred from the outpatient clinic of our institution to
participate on a larger clinical trial. Subjects were considered for study
inclusion if the gas exchange threshold (GET) had been previously
identified in a progressive exercise test (see below). Inclusion criteria
for COPD patients were as follows: forced expiratory volume in 1 s
(FEV1)-to-forced vital capacity ratio 0.7 and postbronchodilator
FEV1  60% predicted; resting arterial PO2  60 Torr at room air; no
evidence of severe pulmonary hypertension (estimated systolic pul-
monary arterial pressure 40 mmHg) and preserved left ventricular
function (ejection fraction 60%) by echo-Doppler cardiography; and
clinical stability for at least 3 mo before the study and no use of oral
steroids in the preceding 6 mo. Subjects in the control group were free
of chronic pulmonary, cardiovascular, immune, and metabolic dis-
ease. Before entering the study, all healthy controls were submitted to
clinical evaluation, and they were screened by pulmonary function
tests, analysis of blood biochemistry, electrocardiography, echocardi-
ography, and a stress exercise testing. To minimize the confounding
effects of regular physical activity on the pathophysiology of exercise
intolerance in COPD, we studied only patients and healthy controls
who were sedentary during the year preceding admission to the study.
All participants signed a written, informed consent form. The study
protocol was approved by the Medical Ethics Committee of the
Federal University of Sa˜o Paulo/Sa˜o Paulo Hospital, Brazil.
Study Protocol
Subjects performed a ramp-incremental exercise test (5–10 W/min
in patients and 15–20 W/min in controls) to determine parameters of
aerobic function during exercise (52). The tests were performed on an
electronically braked cycle ergometer (Corival 400, Lode) at 60 rpm,
and they were preceded by an unloaded baseline pedaling at 0 W for
2 min.
The difference between V˙ O2p at the GET (V˙ O2p GET) and V˙ O2p at
peak exercise (V˙ O2p peak) (V˙ O2p peak-GET) was determined from the
ramp test. On a separate day, subjects performed a constant work rate
exercise test at the same pedaling rate to the Tlim (min) at an intensity
chosen to elicit a V˙ O2p that exceeded the V˙ O2p GET by a value of
40–50% of the V˙ O2p peak-GET (75% peak work rate). Tlim was
defined as the time point in which the patients signaled to stop
exercising or could not maintain the required pedaling rate for 10 s,
despite being encouraged by the investigators.
Measurements
Pulmonary function tests. Spirometric tests were performed by
using the CPF System (Medical Graphics-MGC, St. Paul, MN), with
airflow being measured by a calibrated Pitot tube (PreVent Pneumo-
tach). The subjects completed at least three acceptable maximal forced
and slow expiratory maneuvers after the inhalation of 400 	g of
salbutamol via metered-dose inhaler. Forced vital capacity (liters),
FEV1 (liters), and inspiratory capacity (liters) were recorded. Carbon
monoxide diffusing capacity was measured by the single-breath tech-
nique, and “static” lung volumes were obtained by body plethysmog-
raphy. Arterial partial pressure for O2 and CO2 were determined in
standard anaerobic conditions (Torr).
Exercise tests. V˙ O2p (ml/min), pulmonary carbon dioxide output
(V˙ CO2p; ml/min), minute ventilation (V˙ E; l/min), and end-tidal partial
pressures for O2 and CO2 (Torr) were measured breath by breath
using a computer-based system (CardiO2 System, Medical Graphics).
Gas exchange variables measured during the incremental test were
averaged every 15 s, and V˙ O2p peak was defined as the highest value
achieved during the test. Heart rate (HR; beats/min) was determined
using the R-R interval from a 12-lead electrocardiogram. Arterial
oxyhemoglobin saturation was determined by pulse oximetry [(SpO2),
%; POX 010-340, Mediaid, Torrance, CA] with its analog signal
being directed to the system. Subjects were also asked to rate their
“shortness of breath” at exercise cessation using the 0–10 Borg’s
category ratio scale. The V˙ O2p GET was estimated by the gas-exchange
method, inspecting visually the inflection point of V˙ CO2p with regard
to V˙ O2p (modified V-slope) (8) and by the ventilatory method when
V˙ E-to-V˙ O2p ratio and end-tidal partial pressure of O2 increased, while
V˙ E-to-V˙ CO2p ratio and end-tidal partial pressure of CO2 remained
stable. The reading was performed independently by two experienced
observers without knowledge of other results or subject identities.
Skeletal muscle oxygenation. Skeletal muscle oxygenation profiles
of the left vastus lateralis were evaluated with a commercially avail-
able near-infrared spectroscopy (NIRS) system (Hamamatsu NIRO
200, Hamamatsu Photonics KK). The theory of NIRS has been
described in detail elsewhere (17). Briefly, one fiber-optic bundle
carried the near-infrared light produced by the laser diodes to the
tissue of interest, while a second fiber-optic bundle returned the
transmitted light from the tissue to a photon detector in the spectrom-
eter. The intensity of incident and transmitted light were recorded
continuously and, along with the relevant specific extinction coeffi-
cients, used to measure changes in the oxygenation status of hemo-
globin  myoglobin (Hb  Mb). A set of optodes was placed on the
belly of the vastus lateralis muscle midway between the lateral
epicondyle and greater trochanter of the femur. The optodes were
housed in an optically dense plastic holder, thus ensuring that the
position of the optodes, relative to each other, was fixed and invariant.
The optode assembly was secured on the skin surface with tape and
then covered with an optically dense, black vinyl sheet, thus mini-
mizing the intrusion of extraneous light and loss of near-infrared light.
The variables assessed by NIRS are the concentration of oxygen-
ated, deoxygenated, and total Hb. Among the NIRS variables, several
laboratories have adopted the deoxy-Hb/Mb signal (deoxy-Hb con-
centration [HHb]) as the preferred indicator of changes in muscle
microvascular oxygenation during exercise (15, 16, 19, 24, 28). The
[HHb] response to exercise is then considered a proxy of O2 extrac-
tion in the microcirculation, reflecting the balance between O2 deliv-
ery and utilization. The device used herein did not measure the
reduced scattering of the tissue, preventing determination of absolute
values of [HHb] (in 	M). Therefore, the [HHb] values were recorded
as a change () from baseline in units of micromoles per centimeter.
The NIRS system was “zeroed” during the unloaded cycling portion
of the tests.
Central hemodynamics. Q˙ T (l/min) and stroke volume (SV; liters)
were measured noninvasively throughout the constant work rate test
using impedance cardiography (PhysioFlow PF-05, Manatec Biomed-
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ical). The PhysioFlow device and its methodology have been thor-
oughly described elsewhere (13). Before each exercise test, the system
was autocalibrated, taking into consideration age, stature, body mass,
and blood pressure values. Signal quality was verified by visualizing
the ECG tracing and its first derivative and the impedance waveform
with its first derivative. In preliminary experiments, the coefficient of
variation for changes in Q˙ T and SV during exercise were 3.3 and
4.1%, respectively. In these preliminary trials, the changes in Q˙ T
measured by impedance cardiography were consistent with those
predicted from V˙ O2p values using the submaximal Q˙ T-V˙ O2p relation-
ship described in COPD patients (data not shown) (29, 35).
Kinetics Analysis
The breath-by-breath V˙ O2p, SpO2, NIRS oxygenation, and hemo-
dynamic (Q˙ T, SV, and HR) data were interpolated second by second
before kinetics analysis (SigmaPlot 10.0, Systat Software, San Jose,
CA). The V˙ O2p responses to exercise in the intensity domain used in
our investigation are characterized by the presence of a slow compo-
nent, which may also be observed in Q˙ T measurements. Based on our
experience with pulmonary gas exchange responses to exercise in
COPD patients, we anticipated that determination of the onset or
emergence of the slow component in this population would require
ensemble averaging of several transitions. Since we used data from a
single transition (see Methodological Considerations), we opted to fit
V˙ O2p, Q˙ T, SV, and HR data from 30 s of baseline pedaling to 180 s
after the onset of exercise. Using this approach and Eq. 2 (see below),
we ensured that the same amount of data was included in the kinetic
analysis of V˙ O2p and hemodynamics for each subject (controls and
patients), minimizing model-dependent effects on our results. For
[HHb] kinetics, the analyses were conducted on data from 30-s
baseline cycling to the first 60 s following the increase in work rate to
minimize distortion of the curve-fitting seen when longer periods are
analyzed (15, 16, 18, 19). Theoretical (18) and empirical studies (15,
16, 24) suggest the primary phase of the HHb response is complete
within this time window. To reduce the potential influence of low
SpO2 values on [HHb] in the patient group, the following correction([HHb]corr) was applied:

HHbcorr 
HHb 1 SpO2 
HHb (1)




Yb Ap  
1 etTDp/p (2)
where [Y] is the variable under analysis the subscripts b and p are
baseline unloaded cycling and primary component, respectively; and
A is amplitude, TD is time delay, and  is time constant of the
exponential response of interest. In the analysis of Q˙ T, HR, and SV,
the TDp was dropped from the equation. For V˙ O2p analysis, we deleted
the data relative to the first 20 s after exercise onset, i.e., the
cardio-dynamic phase (34). Therefore, pV˙ O2p represents the time
course of the primary component of the response, an estimate of the
muscle V˙ O2 kinetics (23, 53). The overall kinetics of [HHb] (approx-
imate time to reach 63% of the response following the onset of
exercise) were determined by the mean response time (MRT   
TD). In addition, the amplitude of the “slow component” of V˙ O2p, Q˙ T,
and [HHb] was estimated as the change from 3 min to the end of
exercise (end-3) (39).
Statistical Analysis
The SPSS version 13.0 statistical software was used for data
analysis (SPSS, Chicago, IL). Results were summarized as means 
SD, or median and ranges for symptom scores. To contrast between-
subject resting and exercise responses, nonpaired t or Mann-Whitney
tests were used, as appropriate. One-way ANOVA was used to
contrast MRT values: a post hoc analysis was performed with
Scheffe´’s test when appropriate. Pearson’s product-moment correla-
tion was used to assess the level of association between continuous
variables. A z-test was used to determine if the amplitude of the slow
component of V˙ O2p, Q˙ T, and [HHb] was significantly different from
zero. The level of statistical significance was set at P  0.05 for all
tests.
RESULTS
Subject Characteristics and Exercise Tolerance
Subjects’ resting characteristics are presented in Table 1.
There were no between-group differences in age and body
mass index. As expected from the inclusion criteria, patients
had moderate-to-severe airflow obstruction with increased
“static” lung volumes and moderate reductions in carbon mon-
oxide diffusing capacity. Seven patients were classified as
GOLD stage II, with the remaining patients being considered
as GOLD stages III-IV (33).
V˙ O2p peak, peak work rate, and V˙ O2p GET were significantly
reduced in patients compared with controls; in contrast, V˙ E-to-
maximal voluntary ventilation ratio and dyspnea scores were
higher in patients (Table 2). Six patients had exercise-related
oxyhemoglobin desaturation, i.e., SpO2 decrease 4% (lowest
values at peak exercise ranging from 86 to 89%). The tolerance
to high-intensity, constant work rate exercise (Tlim) was sig-
nificantly reduced in patients compared with controls (640 
95 s vs. 371  100 s; P  0.001). In similarity with the
maximal exercise test, V˙ E-to-maximal voluntary ventilation
ratio and dyspnea were higher in patients, with six patients
showing a significant decrease in SpO2 (lowest values at exer-
cise cessation ranging from 86 to 88%).
Pulmonary Gas Exchange and Cardiovascular Adjustments
Representative responses of V˙ O2p and Q˙ T are shown in
Figs. 1 and 2, respectively. The dynamics of V˙ O2p were
slower in patients than controls (Table 3, Fig. 3). In asub-
Table 1. Resting characteristics of normal controls




Age, yr 61.46.3 59.87.9
Body mass index, kg/m2 24.33.0 25.12.2
Pulmonary function
FEV1, liters 3.310.50 1.050.58*
FEV1, %predicted 99.69.4 44.015.8*
FVC, %predicted 103.210.1 84.012.3*
FEV1/FVC 94.45.8 46.017.8*
TLC, %predicted 87.62.3 119.03.7*
RV, %predicted 103.954.4 165.052.8*
IC, %predicted 97.011.3 75.521.3*




Values are means  SD; n, no. of subjects. COPD, chronic obstructive
pulmonary disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital
capacity; TLC, total lung capacity; RV, residual volume; IC, inspiratory
capacity; DLCO, lung diffusing capacity for carbon monoxide; PaO2 and PaCO2,
arterial PO2 and PCO2, respectively; SaO2, arterial O2 saturation. *P  0.05.
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group of subjects in whom the tests were repeated (4
patients and 5 controls), the coefficient of variation for
V˙ O2p averaged 6.8 and 8.4%, respectively. There was a
significant inverse relationship between V˙ O2p and Tlim in
COPD patients (r  0.70, P  0.01; Fig. 4) and when data
from all subjects were pooled together (r  0.56, P 
0.05). As expected, a V˙ O2p “slow” component was found in
all subjects (P  0.05). There were no between-group
differences in the magnitude of the V˙ O2 slow component
[V˙ O2p (end-3)  202  99 vs. 185  89 ml/min for patients
and controls, respectively], and the relationship between
V˙ O2p (end-3) and Tlim was not significant in either group
(P  0.05).
The increase in Q˙ T was slower in patients compared with
controls and longer than those of V˙ O2p in both groups (Table 3,
Fig. 3). To gain further insights into the slowing of Q˙ T of
COPD patients, we evaluated the kinetics of HR and SV
(Fig. 5). The dynamics of both variables were significantly
slower in patients compared with controls (HR: 61.4  14.2 vs.
86.7  13.9 s; SV: 42.3  10.1 vs. 64.3  11.0 s, P  0.01).
In similarity with V˙ O2p, a slow component of Q˙ T was found in
all subjects (P  0.05). There were no significant differences
in the magnitude of the Q˙ T slow component in patients and
controls [Q˙ T(end-3)  1.74  0.51 vs. 1.61  0.70 l/min,
respectively]. Moreover, Q˙ T(end-3) and Tlim were not signif-
icantly related in either group (P  0.05).
Muscle Oxygenation Responses
The dynamics of SpO2-corrected [HHb] values for a repre-
sentative patient and a normal control are shown in Fig. 6. As
previously described, the [HHb] response displayed a region in
which the signal remained stable or decreased transiently
(determined here by the time delay) (e.g., Fig. 6). All subjects
showed a transient decrease in [HHb] early into the exercise,
with similar duration in both groups (Table 3). After this phase,
the [HHb] increased rapidly with response kinetics that were
faster than the V˙ O2p and Q˙ T responses in both groups (Table 3,
Fig. 3). [HHb] (Table 3) and MRT-[HHb] (Fig. 3) were
significantly faster in patients compared with normal controls.
A slow-component of [HHb] was observed in all subjects of
the control group [HHb](end-3) (P  0.05). In contrast, only
four patients displayed a slow component of the [HHb]
response. The [HHb](end-3) was significantly related to
V˙ O2p (end-3) in the control group (r  0.72, P  0.01), but not
in patients (P  0.38).
Dynamics of Estimated Q˙ O2 mv
We also calculated an indirect index of the dynamics of Q˙ O2 mv(Q˙ O2 mv  V˙ O2p/MRT[HHb]) (see DISCUSSION for further elab-
oration). This ratio was significantly higher in patients com-
pared with controls (4.9  1.2 vs. 2.5  0.6, respectively; P 
0.01), suggesting that Q˙ O2 mv adapted at a slower rate in patients.Interestingly, Q˙ O2 mv was closely related to MRT-Q˙ T (Fig. 7),
suggesting that the dynamics of Q˙ O2 mv followed the response
characteristics of systemic (“central”) O2 delivery.
DISCUSSION
Several aspects make this study a novel investigation.
Specifically, this is the first study to measure V˙ O2p, Q˙ T, and
tissue oxygenation kinetics simultaneously following the
onset of heavy-intensity leg cycling exercise in patients with
moderate-to-severe COPD. This is the initial step to estab-
lish if key determinants of the dynamic matching of central
and peripheral (microvascular) O2 delivery-to-V˙ O2 are im-
paired by COPD and set the stage for future interventional
studies. We found that V˙ O2p kinetics were slower in COPD
patients than in controls and correlated with the tolerance to
sustain heavy-intensity exercise. In addition, compared with
the age-matched controls, COPD patients displayed slower
kinetics of Q˙ T and faster dynamics of [HHb]. Interpretation
of the latter as an estimate of muscle microvascular O2
extraction suggests that the dynamics of muscle Q˙ O2 mv were
slower in COPD patients. Accordingly, a qualitative index of Q˙
O2 mv kinetics (ratio of V˙ O2p to MRT[HHb]) was greater in
COPD patients and was closely related to the overall kinetics
of Q˙ T
.
These data, therefore, indicate that impaired central
and peripheral cardiocirculatory adjustments following the
onset of heavy-intensity exercise negatively impact the
dynamic matching of O2 delivery and utilization in patients
with COPD.
Table 2. Physiological and perceptual responses at peak incremental and constant work rate exercise cessation in controls
and patients with COPD
Variables
Incremental Exercise Constant Work Rate Exercise
Controls COPD Controls COPD
n 11 10 11 10
Power, W 13015 9124* 9517 W 7016*
V˙ O2, ml/min 1,595256 1,320194* 1,388197 1,158218*
V˙ CO2, ml/min 1,860343 1,427330* 1,490298 1,227303*
RER 1.190.12 1.070.14 1.100.10 1.050.08
V˙ O2 at the GET, ml/min 1,215202 1,008174* — —
V˙ E, l/min 67.213.9 43.89.4* 53.811.7 41.710.8*
V˙ E/MVV 0.350.08 0.880.10* 0.300.06 0.860.09*
Heart rate, %predicted 889.8 82.59.6 78.48.7 75.310.1
SpO2, % 954 923 944 922
Dyspnea scores 4 (2–9) 7 (3–9)* 3 (1–7) 7 (4–10)*
Leg effort scores 5 (4–10) 7.5 (0–10) 5 (4–8) 7 (1–9)
Values are means  SD with the exception of symptoms (median and range); n, no. of subjects. V˙ O2, oxygen uptake; V˙ CO2, carbon dioxide output; RER,
respiratory exchange rate; GET, gas exchange threshold; V˙ E, minute ventilation; MVV, maximal voluntary ventilation; Spo2 oxyhemoglobin saturation by pulse
oximetry. *P  0.05 (between-group differences in a given exercise testing protocol).
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V˙ O2p Kinetics and Tolerance to Heavy-intensity Exercise
Several groups have reported that V˙ O2p kinetics are slowed
by healthy aging (9, 11, 15, 16), and this could be due to
impairments in the dynamics of O2 delivery (15, 16). In
general, data from our control group describing the kinetics of
V˙ O2p and central cardiovascular responses to heavy exercise
are in close agreement with previous studies (9, 11, 15, 16). In
COPD patients, the kinetics of V˙ O2p during moderate-intensity
(sublactate threshold) exercise are 45–65% slower than in
healthy aged controls (34, 36, 40). We extended these findings
to show that V˙ O2p kinetics during heavy-intensity exercise
were, on average, 74% slower in COPD patients (Table 3).
Moreover, phase II V˙ O2p kinetics displayed an inverse relation-
ship with tolerance to sustain heavy-intensity exercise (Fig. 4).
These data are consistent with those from the study of Puente-
Maestu and coworkers (40), who found a significant inverse
correlation between increase in Tlim during moderate exercise
and the decrease in V˙ O2p induced by exercise training in
patients with advanced COPD. Our data and those of Puente-
Maestu et al. (40) collectively suggest that abnormalities on
muscle energetics following the onset of exercise may contrib-
ute to the patient’s ability to sustain dynamic exercise for
prolonged periods of time. Thus resolution of factors that
promote the slowing of V˙ O2p response in COPD might prove to
be useful in guiding therapeutic efforts to increase the tolerance
to heavy-intensity exercise in this population.
Potential Mechanisms for a Slower V˙ O2p Kinetics
at Heavy-intensity Exercise in COPD
The factors generally considered as limiting the kinetics of
V˙ O2 are the adequacy of O2 delivery during the transient phase
following the onset of exercise (27) and/or the activity of
intracellular biochemical reactions that stimulate mitochon-
drial V˙ O2, also called “metabolic inertia” (23). Several groups
emphasize the role of O2 delivery limitation to V˙ O2 kinetics in
the elderly (9, 15, 16) and in chronic diseases (5, 6, 10). The
argument for O2 delivery limitation of V˙ O2 kinetics in old
subjects is based on slower adaptation of HR (16) and age-
related changes in arteriolar vasodilation (7). More recently,
these arguments have been strengthened by faster kinetics of
muscle deoxygenation at the onset of heavy-intensity exercise
in old compared with young individuals (9, 15, 16), suggesting
that, in the former group, the dynamics of muscle perfusion
were slower in relation to the kinetics of muscle V˙ O2 (18).
Moreover, interventions that appear to increase muscle oxy-
genation promoted a speeding of V˙ O2p kinetics in the elderly
(15). If derangements in O2 delivery explain, at least partially,
the slowing of V˙ O2 kinetics with healthy aging, it is conceiv-
able that any pathological condition that could further slow the
Fig. 1. Pulmonary O2 uptake (V˙ O2p) kinetics (phases II and III) at the onset of
heavy-intensity exercise in a representative age-matched control (A) and a
patient with chronic obstructive pulmonary disease (COPD; B). Note the
slower kinetics [higher time constant () of the “primary” component] in the
COPD patient compared with the control subject.
Fig. 2. Cardiac output (Q˙ T) adjustment at the onset of heavy-intensity exercise
in a representative age-matched control (A) and a patient with COPD (B). Note
the slower “central” cardiovascular adaptation to exercise [higher mean re-
sponse time (MRT)    time delay (TD)] in the COPD patient compared
with the control subject.
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dynamics of convective O2 delivery in old individuals (e.g.,
COPD) would have a negative impact on the kinetics of V˙ O2p
during heavy-intensity exercise. However, to elucidate the
main determinant of slower V˙ O2p kinetics, one must consider
which of the potential limiting factors (intramyocyte metabolic
machinery or O2 delivery) is affected to a greater extent, if any,
by the disease.
Patients with COPD have decreased oxidative enzyme ac-
tivity and mitochondrial volume density and an increase in the
percentage of type II fibers (as reviewed in Ref. 3). This
intrinsic skeletal muscle dysfunction could, at least partially,
explain the slowing of V˙ O2p kinetics in COPD patients. Con-
sistent with this notion, V˙ O2p kinetics of COPD patients per-
forming moderate exercise were not affected by hyperoxic gas
breathing (45), which was assumed to increase muscle O2
delivery. Moreover, exercise training speeded the kinetics of
V˙ O2p with no effect on HR dynamics, which is usually consid-
ered an indicator of Q˙ T (and O2 delivery) kinetics (12). Thus,
in lieu of similar O2 delivery following the onset of heavy-
intensity exercise, intrinsic skeletal muscle dysfunction would
solely explain the slower V˙ O2p kinetics observed in the present
study (Figs. 1 and 3). Several variables measured and estimated
in our study suggest this may not be the case during heavy-
intensity exercise in patients with moderate-to-severe COPD.
Dynamics of Q˙ T During Dynamic Exercise in COPD
A slower adjustment of HR to moderate exercise in patients
with COPD than in age-matched controls has been previously
described (34, 40). Numerous factors (see below) can also
impair the adjustment of SV following the onset of exercise in
COPD, such that HR dynamics may underestimate the impact
of the disease on the kinetics of Q˙ T. Our study is the first to
show that Q˙ T (approximately O2 delivery) kinetics were 44%
slower in COPD patients compared with healthy peers. This
was a consequence of slower SV and HR kinetics, where, on
average, the SV response appeared to be affected to a greater
extent than HR (52 vs. 40% higher time constant). This
demonstrates that central cardiovascular responses that help
maintain the adequacy of O2 delivery to contracting muscles
are impaired in COPD. In the present study, these derange-
ments are unlikely to be related to intrinsic cardiovascular
disease, as the patients were clinically and functionally
screened for significant inotropic dysfunction and severe pul-
monary hypertension.
Potential explanations for slower on-transient Q˙ T (i.e., HR
and SV) kinetics in COPD are as follows: 1) autonomic
imbalance (26), 2) pulmonary vascular alterations (including
pulmonary hypertension) (14), and/or 3) effects of mechanics
of breathing on SV (1, 2, 49, 50). The increase in HR through
sympathetic activation is slower than that accomplished by
parasympathetic withdrawal (51). The shift toward greater
sympathetic activity with COPD (26) would promote slowing
of HR and thereby Q˙ T dynamics. Regarding the SV response,
the deleterious cardio-circulatory consequences of increasing
Fig. 3. MRT (in s) (MRT    TD) of V˙ O2p, Q˙ T, and deoxy-hemoglobin
concentration ([HHb]) measured by near-infrared spectroscopy at the onset of
heavy-intensity exercise in age-matched controls (open bars) and patients with
COPD (solid bars). Note that the dynamics of V˙ O2p and Q˙ T were slower in
patients with COPD; in contrast, they presented with faster [HHb] kinetics than
the healthy controls. Values are means (SD). *P  0.05 for between-group
comparisons; †P  0.05 for within-group comparisons of V˙ O2p vs. Q˙ T and
[HHb]; ‡P  0.05 for within-group comparisons of Q˙ T vs. [HHb].
Fig. 4. Significant inverse relationship between time to intolerance in response
to heavy-intensity exercise and the  of the “primary” component of the
on-transient V˙ O2p kinetics in patients with COPD (●) but not in healthy
controls ().
Table 3. Kinetic parameters of V˙ O2p, Q˙ T, and 
HHb for controls and patients with COPD
Parameters
V˙ O2p Q˙ T 
HHb
Controls COPD Controls COPD Controls COPD
Baseline 521100 510110 6.41.5 7.81.7 0.024.1 2.310.1
A 865156 691250 5.42.3 6.42.3 73.346.7 60.130.5
, s 42.112.9 72.923.3* 66.610.8 96.231.6* 9.81.4 6.71.2*
TD, s 6.55.0 7.87.7 — 9.23.2 10.33.9
Values are means  SD. V˙ O2p, pulmonary V˙ O2; Q˙ T, cardiac output; 
HHb, deoxyhemoglobin concentration; A, amplitude; , time constant; TD, time delay.
*P  0.01.
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lung volumes in patients with COPD, especially during exer-
cise, have been emphasized (1). More specifically, the devel-
opment of high mean intrathoracic pressures as V˙ E increases in
the transitional phase could dynamically impair the rate of right
ventricle filling and left ventricle emptying in these patients.
Recently, Vogiatzis et al. (49) showed that normal subjects
breathing with simulated expiratory flow limitation, similar to
that found in advanced COPD, had significantly slower off-
transient V˙ O2p kinetics compared with control values, suggest-
ing that alterations in the mechanics of breathing can reduce
muscle O2 delivery enough to affect the kinetics of V˙ O2p.
Another relevant mechanism for a reduced O2 delivery to the
working muscles could be related to the pattern of respiratory
muscle recruitment in patients with advanced COPD. Aliverti
and Macklem (1) postulated that slowing the velocity of
shortening of the abdominal expiratory muscles, by increasing
expiratory pressures, had major adverse effects on the circula-
tion impeding venous return and decreasing Q˙ T. Considering
that some patients seem to recruit massively the abdominal
muscles (2), it is conceivable that these adjustments could
impair peripheral O2 delivery. Moreover, respiratory muscle
work during heavy exercise can divert a fraction of the Q˙ T from
leg muscles, contributing to exercise intolerance (25). Since the
work of breathing is particularly increased in COPD patients
(1), following the onset of exercise, a larger portion of Q˙ T may
be directed to the diaphragm, predisposing to slower kinetics of
peripheral muscle blood flow in COPD compared with con-
trols. These findings support the notion that central cardiovas-
cular responses to exercise and peripheral O2 delivery can be
Fig. 5. Heart rate (top) and stroke volume
(bottom) dynamics at the onset of heavy-
intensity exercise in a representative age-
matched control (left) and a patient with
COPD (right). Note that both responses were
slower (higher MRT    TD) in the COPD
patient compared with the control subject.
bpm, Beats/min.
Fig. 6. Changes in [HHb] measured by near-infrared spectroscopy at the onset
of heavy-intensity exercise in a representative age-matched control and a
patient with COPD. Values are expressed relative to the change of variation
found in each test. Note the faster kinetics (lower MRT    TD) in the
COPD patient, i.e., O2 extraction rate was faster in patients than controls.
Fig. 7. Significant positive relationship between an index of the kinetics of
microvascular O2 delivery ( of the “primary” component of the on-transient
V˙ O2p/MRT of the changes in [HHb]) and the kinetics of systemic O2 delivery,
as estimated by the dynamics of Q˙ T (MRT-Q˙ T), at the onset of heavy-intensity
exercise in healthy controls and patients with COPD.
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significantly impaired by abnormal pulmonary-mechanical re-
sponses in patients with moderate-to-severe COPD.
Kinetics of Muscle Oxygenation
Tissue oxygenation kinetics during exercise are probably the
most relevant assessment to determine the effects of COPD on
the dynamic supply of O2 in relation to V˙ O2 of the muscle. The
finding that [HHb] kinetics were faster than the phase II V˙ O2p
and Q˙ T dynamics in both COPD patients and controls is in
close agreement with data from previous investigations in
young (15, 19, 24) and old adults (15, 16). This appears to stem
from differences in the profile of muscle V˙ O2 (monoexponen-
tial) and muscle O2 delivery (a biphasic response) (18, 38, 39).
The faster increase in [HHb] in patients than controls, an
estimate of muscle microvascular O2 extraction kinetics (16,
18, 24), suggests that any cardiovascular dysfunction related to
COPD was sufficient to impair the dynamic matching of
muscle Q˙ O2 mv and V˙ O2 during the on-transient phase of heavy
exercise (Figs. 3 and 6).
The slowing of Q˙ T reported here is a feasible explanation for
the sluggish increase in Q˙ O2 mv and speeding of [HHb] response.
This theory is supported by the close association between the
kinetics of Q˙ T and our qualitative index of Q˙ O2 mv dynamics(V˙ O2p/MRT[HHb]) (Fig. 7). However, a temporally reduced
O2 availability could also be related to impaired muscle mi-
crovascular function in response to exercise in patients with
COPD, independent of the central cardiovascular dysfunction
(see above). Heightened sympathetic vasoconstriction at rest
will slow the increase in muscle blood flow (48). Among the
known muscle vasodilatory mediators, much emphasis has
been given to nitric oxide (NO), especially in disease states.
Blockade of NO synthase hastens the increase in O2 extraction
in healthy rat muscles (20). Furthermore, it has been demon-
strated that conditions associated with vascular endothelial
dysfunction and reduced vascular NO availability, such as
diabetes (6), aging (9, 46), and heart failure (10), are charac-
terized by slowing of muscle O2 delivery and speeding of the
increase in microvascular O2 extraction during contractions.
Surprisingly, there is a lack of data on peripheral endothelial
function in COPD patients. However, COPD patients are
usually former smokers, have increased plasma levels of tumor
necrosis factor-, and reactive oxygen species (as reviewed in
Ref. 21). All of these factors will contribute to lower NO
availability, predisposing the patients to microvascular dys-
function (55). Therefore, although the sluggish increase in
muscle Q˙ O2 mv may be determined mainly by the central cardio-
vascular effects of COPD that slows the kinetics of Q˙ T, as
suggested by Fig. 7, microvascular dysfunction should not be
neglected in these patients.
In our older controls, muscle deoxygenation displayed a
slow-component response similar, and directly related, to that
observed in V˙ O2p. This is in close agreement with studies in
younger subjects (15, 16) and consistent with the notion that
most of the slow-component observed in the V˙ O2p response
comes from the exercising legs (37). Another interesting find-
ing in the present study was the dissociation between the
presence and magnitude of the slow component of V˙ O2p and
[HHb] in patients with COPD. While the slow component of
V˙ O2p was found in all patients, only four of them showed a
similar profile in the [HHb] response. These data might indi-
cate that the determinants of the “extra” V˙ O2p can vary in
individual COPD patients. Future studies, for instance, should
investigate whether the extra V˙ O2p could be explained, at least
partially, by increased ventilatory cost of exercise and/or
higher work of breathing at a given ventilation.
Methodological Considerations
Due to the noninvasive nature of our study, several meth-
odological aspects need further clarification. First and fore-
most, we assumed that the kinetics of deoxy-Hb/Mb measured
at a single site reflects the time course of muscle microvascular
O2 extraction following the onset of exercise. Although there is
ongoing controversy regarding the primary determinant of the
NIRS signal (31, 47), several studies have used [HHb] from a
single site in the quadriceps muscle as a proxy of tissue
“fractional” O2 extraction (6, 15, 16, 18, 19, 24) and provided
extensive discussion on this topic. A key argument supporting
the use of [HHb] as an approximation of O2 extraction dynam-
ics is the generally similar characteristics of [HHb] response in
humans (15, 16, 18, 19, 24) compared with O2 extraction
dynamics measured in skeletal muscles (9, 10, 23) and calcu-
lated in computer simulations (18). In addition, the NIRS
technology employed in our study does not allow measurement
of tissue-scattering properties. This prevented calculation of
absolute values of [HHb], but it is unlikely that it would have
affected the kinetics profile of HHb compared with results
yielded by measuring scattering and incorporating it in our
calculations (31).
Other important issues are the use of data from a single
transition to determine differences in V˙ O2p, Q˙ T, and [HHb]
kinetics, and assumption that the primary component of V˙ O2p
kinetics represents the dynamics of muscle V˙ O2 in COPD
patients. Although the use of one transition may limit resolu-
tion of small differences in kinetic responses, especially for
V˙ O2p and Q˙ T, the differences between COPD and controls were
large enough to be detected statistically, as suggested by the
study of Puente-Maestu et al. (41). The kinetics of the primary
component of V˙ O2p response is widely used as an indicator of
the muscle V˙ O2 response, as the time course of the primary
component has been shown (24) or predicted (4) to closely
reflect (within 10%) the muscle V˙ O2 response. Grassi et al.
(24), for instance, found a close similarity between the kinetics
of leg V˙ O2 and V˙ O2p during cycling exercise, and Rossiter et al.
(43) demonstrated that phosphocreatine breakdown (from 31P-
NMR), which is considered to be closely linked to mitochon-
drial O2 consumption (32), followed a similar dynamic profile
to that of the primary component of V˙ O2p during moderate-
intensity exercise. However, slowing of muscle blood flow
may create a discrepancy between muscle and pulmonary V˙ O2
kinetics, where the V˙ O2p response will become faster than the
muscle V˙ O2 dynamics due to changes in the leg-to-lung transit
delay (39). Therefore, based on the Q˙ T and [HHb] kinetics
determined in our study, we may have underestimated the
slowness of muscle V˙ O2 kinetics in patients with COPD per-
forming heavy-intensity exercise.
Conclusions
In general, our data show that patients with moderate-to-
severe COPD have impaired central and peripheral cardiovas-
cular responses to exercise that lead to slower kinetics of Q˙ T
and faster muscle deoxygenation profile following the onset of
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heavy-intensity exercise. The latter effects are in opposite
direction to that expected to be seen when the slowing of V˙ O2p
kinetics occur due only to intrinsic muscle metabolic distur-
bances, and there is a surplus of O2 delivery to contracting
muscles. Our interpretation of the data, therefore, is that
derangements in convective O2 delivery to skeletal muscles
might contribute substantially to limit the kinetics of V˙ O2p and
exercise tolerance during heavy-intensity exercise in patients
with moderate-to-severe COPD. However, without knowing
the absolute values of microvascular PO2 following the onset of
contractions, and if those were low enough to impair O2
transfer from blood to muscle, we cannot establish with cer-
tainty that the slothful kinetics of V˙ O2p in COPD were a
consequence of reduced O2 availability. This can be resolved
by studies examining the effects of interventions that increase
muscle O2 delivery, or speed its dynamics, on the kinetics of
V˙ O2 at high-intensity exercise in patients with COPD.
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